Pot Stock Buy Alert: What Long-Term Cannabis Investors Need to Know

Even in its short history, Cannabis investing has been full of victory and defeat. In 2018, every pot stock was soaring in value. By 2019, the fortunes were reversed, with the majority of pot stocks falling by at least 50%. Here’s what you need to know: this ride is far from over. In 2020, we could see another upward surge.…

Read More

Is This the Perfect Time to Buy Canopy Growth (TSX:WEED) Stock?

Investing isn’t just about being right; it’s also about being right at the perfect time. In the early 90s you could have predicted that the rising crop of internet startups were likely to create trillions of dollars in value over their lifetime. However, if you’d invested in these companies right away, you would have probably lost all your money in…

Read More

Here’s Why Now Is a Good Time to Get Greedy With Canopy Growth (TSX:WEED) Stock!

The cannabis trade dried up a long time ago. But that’s exactly why I think Canopy Growth (TSX:WEED)(NYSE:CGC), Canada’s top cannabis kingpin and the “safest” way to play the stomach-churning industry, is now worthy of your investment dollars. To make big money as an investor, you’ve got to be like Warren Buffett and be greedy while others are fearful (and…

Read More

Canopy Growth’s (TSX:WEED) Latest 62% Revenue Growth Isn’t Repeatable

Canopy Growth (TSX:WEED)(NYSE:CGC) stock soared over 15% on Friday after the cannabis firm released a strong earnings report that revealed a 62% sequential net revenue growth to $124 million for its fiscal Q3 2019 ended in December 2019. Such high double-digit growth rates, especially on a sequential quarter-over-quarter basis, deserve a huge celebration and should naturally drive the stock price…

Read More

Aurora Cannabis (TSX:ACB) Revenue Falls 26%: Time to Sell the Stock?

This past week, Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) released its earnings for the second quarter of 2020, and they were, predictably, bad. The company reported a 26% drop in net revenue along with a colossal $1.3 billion GAAP net loss. While the net loss was mostly due to a goodwill impairment charge, the company also reported a $80 million adjusted EBITDA loss that…

Read More

Like Canopy Growth (TSX:WEED)? This Pot Stock Is Even Better

Canopy Growth (TSX:WEED)(NYSE:CGC) is a favourite among cannabis investors. With a $10.3 billion market cap, the stock is priced above nearly every competitor. One of the biggest reasons for this valuation is Canopy’s partnership with Constellation Brands. With a $40 billion valuation, Constellation is an industry heavyweight, too. But instead of pot, Constellation is focused on alcohol. Last year, it…

Read More

Why the Hexo (TSX:HEXO) Stock Price Fell 19.8% in January

Cannabis stocks like Hexo (TSX:HEXO)(NYSE:HEXO) had their heads handed to them in January once again, as the downward spiral continues. When a bubble bursts, it falls hard, and Hexo’s stock price is a prime example of this. Down 19.8% in January, 75.6% in the last year and 85.1% from its highs, Hexo stock still carries too much risk and uncertainty for…

Read More

HEXO (TSX:HEXO) Abruptly Changes Auditors: Should Investors Raise Eyebrows?

HEXO Corp (TSX:HEXO)(NYSE:HEXO) announced on Friday, February 7 that it had changed its auditors effective January 31, 2020, and this could raise some investor concerns, considering the cannabis firm was recently “pressured” to restate its earnings. The company has changed its auditors from MNP LLP to PricewaterhouseCoopers LLP, and there has been no statutorily required reportable events upon the change,…

Read More

Top 5 Institutional Shareholders of Canopy Growth Corporation (NYSE: CGC)

Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) has long been one of the leaders in the cannabis sector, alongside other major companies like Aurora Cannabis (NYSE: ACB) (TSX: ACB) and Aphria, Inc. (NYSE: APHA) (TSX: APHA). CGC is down nearly 7% year-to-date in 2020 already. In addition, the stock is heavily shorted, as seen with a short float of 21.31%.…

Read More

3 Reasons Aphria (TSX:APHA) Could Beat Aurora Cannabis (TSX:ACB) in Europe

While the battle among Canadian marijuana producers for Europe market dominance continues to shape up in 2020, clear winners are emerging judging from recent licensing developments, capacity analysis and related strategic moves from the respective challengers.  Aurora Cannabis (TSX:ACB)(NYSE:ACB) and Canopy Growth have enjoyed some first mover advantage after reporting some significant sales run rates in Germany over the past…

Read More